National Capital Surpluse vs Accounts Payable Analysis

NHI Stock

USD 76.91 0.58 0.75%

National Health financial indicator trend analysis is infinitely more than just investigating National Health Investors recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether National Health Investors is a good investment. Please check the relationship between National Health Capital Surpluse and its Accounts Payable accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in National Health Investors. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.

Capital Surpluse vs Accounts Payable

Capital Surpluse vs Accounts Payable Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of National Health Investors Capital Surpluse account and Accounts Payable. At this time, the significance of the direction appears to have very strong relationship.

The correlation between National Health's Capital Surpluse and Accounts Payable is 0.89. Overlapping area represents the amount of variation of Capital Surpluse that can explain the historical movement of Accounts Payable in the same time period over historical financial statements of National Health Investors, assuming nothing else is changed. The correlation between historical values of National Health's Capital Surpluse and Accounts Payable is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Capital Surpluse of National Health Investors are associated (or correlated) with its Accounts Payable. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Accounts Payable has no effect on the direction of Capital Surpluse i.e., National Health's Capital Surpluse and Accounts Payable go up and down completely randomly.

Correlation Coefficient

0.89

Relationship Direction	Positive
Relationship Strength	Strong

View All Relationships

Capital Surpluse

Accounts Payable

An accounting item on the balance sheet that represents National Health obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of National Health Investors are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.

Most indicators from National Health's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into National Health Investors current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in National Health Investors. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.

As of now, National Health's Selling General Administrative is increasing as compared to previous years. The National Health's current Enterprise Value is estimated to increase to about 3.7 B, while Discontinued Operations is projected to decrease to under 16.4 M.

	2021	2022	2023	2024 (projected)
Gross Profit	287.1M	268.4M	308.3M	169.0M
Total Revenue	298.7M	278.2M	319.8M	170.8M

Gross Profit Total Revenue

National Health fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Non Currrent Assets Other	Other Assets	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Non Current Assets Total	Net Receivables	Total Current Assets	Other Current Liab	Total Current Liabilities	Accounts Payable	Cash	Cash And Short Term Investments	Common Stock Total Equity	Common Stock	Short Term Debt	Other Liab	Long Term Debt
Total Assets		0.95	0.99	0.69	0.93	-0.06	0.2	0.34	0.92	0.99	0.58	0.99	0.58	1.0	0.9	0.88	-0.37	0.41	0.7	0.25	0.21	0.95	0.95	0.36	-0.19	0.99
Short Long Term Debt Total	0.95		0.92	0.59	0.91	-0.11	0.06	0.39	0.84	0.97	0.6	0.97	0.44	0.94	0.88	0.87	-0.61	0.39	0.67	0.35	0.31	0.89	0.89	0.6	-0.27	0.97
Total Stockholder Equity	0.99	0.92		0.72	0.9	-0.06	0.22	0.33	0.95	0.96	0.59	0.96	0.66	0.99	0.89	0.87	-0.34	0.39	0.69	0.27	0.25	0.95	0.94	0.31	-0.16	0.95
Property Plant And Equipment Net	0.69	0.59	0.72		0.67	0.01	0.44	0.13	0.7	0.65	0.4	0.65	0.63	0.72	0.57	0.52	-0.14	0.26	0.5	0.1	-0.04	0.61	0.62	0.09	0.14	0.64
Net Debt	0.93	0.91	0.9	0.67		0.17	0.13	0.46	0.82	0.94	0.39	0.94	0.35	0.92	0.91	0.87	-0.33	0.62	0.84	0.33	0.19	0.89	0.89	0.36	-0.33	0.96
Retained Earnings	-0.06	-0.11	-0.06	0.01	0.17		-0.28	0.54	0.04	-0.1	-0.83	-0.06	-0.1	-0.07	0.13	0.1	0.25	0.85	0.6	0.36	0.17	0.19	0.2	-0.11	-0.46	-0.03
Non Currrent Assets Other	0.2	0.06	0.22	0.44	0.13	-0.28		-0.52	0.14	0.21	0.33	0.18	0.29	0.28	-0.11	-0.19	0.33	-0.34	-0.15	-0.58	-0.59	0.06	0.06	-0.41	0.35	0.16
Other Assets	0.34	0.39	0.33	0.13	0.46	0.54	-0.52		0.35	0.32	-0.23	0.34	0.01	0.29	0.54	0.57	-0.31	0.7	0.62	0.89	0.78	0.47	0.48	0.41	-0.46	0.37
Common Stock Shares Outstanding	0.92	0.84	0.95	0.7	0.82	0.04	0.14	0.35		0.85	0.49	0.86	0.77	0.91	0.86	0.85	-0.37	0.45	0.72	0.35	0.34	0.92	0.92	0.34	-0.22	0.85
Non Current Liabilities Total	0.99	0.97	0.96	0.65	0.94	-0.1	0.21	0.32	0.85		0.6	1.0	0.48	0.98	0.89	0.86	-0.39	0.38	0.67	0.21	0.16	0.91	0.91	0.38	-0.2	1.0
Other Stockholder Equity	0.58	0.6	0.59	0.4	0.39	-0.83	0.33	-0.23	0.49	0.6		0.57	0.38	0.59	0.4	0.42	-0.42	-0.44	-0.07	-0.09	0.02	0.34	0.34	0.29	0.25	0.54
Total Liab	0.99	0.97	0.96	0.65	0.94	-0.06	0.18	0.34	0.86	1.0	0.57		0.49	0.98	0.9	0.87	-0.39	0.41	0.69	0.22	0.18	0.93	0.93	0.38	-0.22	1.0
Property Plant And Equipment Gross	0.58	0.44	0.66	0.63	0.35	-0.1	0.29	0.01	0.77	0.48	0.38	0.49		0.61	0.41	0.41	-0.14	0.07	0.28	0.08	0.2	0.61	0.61	0.06	0.24	0.45
Non Current Assets Total	1.0	0.94	0.99	0.72	0.92	-0.07	0.28	0.29	0.91	0.98	0.59	0.98	0.61		0.86	0.83	-0.35	0.38	0.68	0.21	0.17	0.93	0.93	0.32	-0.13	0.97
Net Receivables	0.9	0.88	0.89	0.57	0.91	0.13	-0.11	0.54	0.86	0.89	0.4	0.9	0.41	0.86		0.99	-0.37	0.61	0.8	0.43	0.35	0.9	0.9	0.4	-0.47	0.91
Total Current Assets	0.88	0.87	0.87	0.52	0.87	0.1	-0.19	0.57	0.85	0.86	0.42	0.87	0.41	0.83	0.99		-0.42	0.57	0.77	0.51	0.44	0.88	0.89	0.44	-0.47	0.88
Other Current Liab	-0.37	-0.61	-0.34	-0.14	-0.33	0.25	0.33	-0.31	-0.37	-0.39	-0.42	-0.39	-0.14	-0.35	-0.37	-0.42		-0.07	-0.25	-0.54	-0.57	-0.33	-0.33	-0.98	0.22	-0.39
Total Current Liabilities	0.41	0.39	0.39	0.26	0.62	0.85	-0.34	0.7	0.45	0.38	-0.44	0.41	0.07	0.38	0.61	0.57	-0.07		0.91	0.53	0.32	0.59	0.6	0.2	-0.6	0.45
Accounts Payable	0.7	0.67	0.69	0.5	0.84	0.6	-0.15	0.62	0.72	0.67	-0.07	0.69	0.28	0.68	0.8	0.77	-0.25	0.91		0.51	0.33	0.81	0.82	0.33	-0.55	0.72
Cash	0.25	0.35	0.27	0.1	0.33	0.36	-0.58	0.89	0.35	0.21	-0.09	0.22	0.08	0.21	0.43	0.51	-0.54	0.53	0.51		0.94	0.35	0.36	0.59	-0.39	0.25
Cash And Short Term Investments	0.21	0.31	0.25	-0.04	0.19	0.17	-0.59	0.78	0.34	0.16	0.02	0.18	0.2	0.17	0.35	0.44	-0.57	0.32	0.33	0.94		0.31	0.31	0.59	-0.27	0.18
Common Stock Total Equity	0.95	0.89	0.95	0.61	0.89	0.19	0.06	0.47	0.92	0.91	0.34	0.93	0.61	0.93	0.9	0.88	-0.33	0.59	0.81	0.35	0.31		1.0	0.35	-0.33	0.93
Common Stock	0.95	0.89	0.94	0.62	0.89	0.2	0.06	0.48	0.92	0.91	0.34	0.93	0.61	0.93	0.9	0.89	-0.33	0.6	0.82	0.36	0.31	1.0		0.35	-0.34	0.93
Short Term Debt	0.36	0.6	0.31	0.09	0.36	-0.11	-0.41	0.41	0.34	0.38	0.29	0.38	0.06	0.32	0.4	0.44	-0.98	0.2	0.33	0.59	0.59	0.35	0.35		-0.34	0.39
Other Liab	-0.19	-0.27	-0.16	0.14	-0.33	-0.46	0.35	-0.46	-0.22	-0.2	0.25	-0.22	0.24	-0.13	-0.47	-0.47	0.22	-0.6	-0.55	-0.39	-0.27	-0.33	-0.34	-0.34		-0.26
Long Term Debt	0.99	0.97	0.95	0.64	0.96	-0.03	0.16	0.37	0.85	1.0	0.54	1.0	0.45	0.97	0.91	0.88	-0.39	0.45	0.72	0.25	0.18	0.93	0.93	0.39	-0.26

Click cells to compare fundamentals

National Health Account Relationship Matchups

National Health fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	3.0B	3.1B	2.8B	2.5B	2.5B	1.3B
Short Long Term Debt Total	1.5B	2.0B	1.3B	1.6B	1.1B	618.4M
Total Stockholder Equity	1.5B	1.5B	1.5B	1.3B	1.3B	729.6M
Net Debt	1.4B	1.5B	1.2B	1.1B	1.1B	1.2B
Retained Earnings	(5.3M)	(22.0M)	(84.6M)	(329.6M)	2.5B	2.6B
Non Currrent Assets Other	(308K)	6.8M	7.5M	965K	8.4M	8.0M
Other Assets	304.3M	2.8B	2.5B	45.5M	2.1B	2.2B
Common Stock Shares Outstanding	43.7M	44.7M	45.7M	44.8M	43.4M	32.0M
Liabilities And Stockholders Equity	3.0B	3.1B	2.8B	2.5B	2.5B	1.3B
Non Current Liabilities Total	1.5B	1.5B	1.3B	1.1B	1.1B	559.3M
Other Stockholder Equity	1.5B	1.6B	1.6B	1.6B	(863.1M)	(819.9M)
Total Liab	1.5B	1.6B	1.3B	1.2B	1.2B	610.1M
Non Current Assets Total	2.6B	2.7B	2.3B	2.1B	2.1B	1.2B
Net Receivables	429.4M	390.7M	399.4M	315.0M	330.0M	238.6M
Total Current Assets	463.5M	437.1M	505.2M	379.8M	352.3M	256.7M
Other Current Liab	45.6M	(408.6M)	(34.1M)	(376.4M)	33.1M	34.7M
Total Current Liabilities	92.9M	87.6M	70.2M	70.0M	148.8M	156.2M
Accounts Payable	26.3M	25.2M	23.2M	25.9M	34.3M	36.0M
Cash	5.2M	43.3M	37.4M	19.3M	22.3M	34.0M
Cash And Short Term Investments	5.2M	43.3M	37.4M	19.3M	22.3M	21.2M
Common Stock Total Equity	446K	452K	459K	434K	499.1K	351.3K
Accumulated Other Comprehensive Income	(3.4M)	(7.1M)	(84.6M)	(329.6M)	(350.2M)	(332.7M)
Common Stock	446K	452K	459K	434K	499.1K	355.8K
Short Term Debt	1.2M	458.4M	75.4M	415.4M	75.4M	63.4M
Other Liab	30.4M	23.3M	14.6M	5.1M	4.5M	4.3M
Long Term Debt	1.4B	1.5B	1.2B	1.1B	1.1B	663.6M
Current Deferred Revenue	19.8M	12.6M	5.7M	5.1M	6.0M	4.6M
Other Current Assets	(431.4M)	(431.5M)	(433.6M)	45.5M	7.3M	7.6M
Net Tangible Assets	1.5B	1.5B	1.5B	1.3B	1.5B	1.2B
Capital Surpluse	1.5B	1.5B	1.6B	1.6B	1.8B	1.2B
Deferred Long Term Liab	10.1M	12.6M	5.7M	5.1M	5.8M	4.6M
Long Term Investments	141.5M	246.1M	292.4M	300.0M	344.9M	187.0M

Currently Active Assets on Macroaxis

ESRT	Empire State Realty
C	Citigroup
C	Citigroup
GOOG	Alphabet Inc Class C
DD	Dupont De Nemours

When determining whether National Health Investors offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of National Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of National Health Investors Stock. Outlined below are crucial reports that will aid in making a well-informed decision on National Health Investors Stock:

How To Invest In National

Details

Is National Stock a good investment?

Details

What is National Health's Net Worth?

Details

Largest Diversified REITs Companies

View

Largest Equity Real Estate Investment Trusts (REITs) Companies

View

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in National Health Investors. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.

You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.

Is Diversified REITs space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of National Health. If investors know National will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about National Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.14)

Dividend Share

3.6

Earnings Share

2.91

Revenue Per Share

7.598

Quarterly Revenue Growth

(0.12)

The market value of National Health Investors is measured differently than its book value, which is the value of National that is recorded on the company's balance sheet. Investors also form their own opinion of National Health's value that differs from its market value or its book value, called intrinsic value, which is National Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because National Health's market value can be influenced by many factors that don't directly affect National Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between National Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if National Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, National Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

National Capital Surpluse vs Accounts Payable Analysis

Capital Surpluse vs Accounts Payable

Capital Surpluse vs Accounts Payable Correlation Analysis

Correlation Coefficient

Capital Surpluse

Accounts Payable

National Health fundamental ratios Correlations

National Health Account Relationship Matchups

High Positive Relationship

High Negative Relationship

National Health fundamental ratios Accounts

Currently Active Assets on Macroaxis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Non Current Assets Total	+ 1.0	Total Assets
Total Liab	+ 1.0	Non Current Liabilities Total
Long Term Debt	+ 1.0	Non Current Liabilities Total
Long Term Debt	+ 1.0	Total Liab
Common Stock	+ 1.0	Common Stock Total Equity
Total Stockholder Equity	+ 0.99	Total Assets

Short Term Debt	- 0.98	Other Current Liab
Other Stockholder Equity	- 0.83	Retained Earnings
Other Current Liab	- 0.61	Short Long Term Debt Total
Other Liab	- 0.6	Total Current Liabilities
Cash And Short Term Investments	- 0.59	Non Currrent Assets Other
Cash	- 0.58	Non Currrent Assets Other